Search
Technetium Tc-99m succimer
go.drugbank.com/drugs/DB09436Approved[L40558] The use of technetium Tc-99m succimer for the detection of kidney cortical defects was first approved by the FDA on February 23, 2022, under the market name NephroScan.[L40573] … It works by binding to the cortical region of the kidneys. Technetium Tc-99m succimer is used with gamma scintigraphy or single-photon emission computed tomography (SPECT).
Sarocladium strictum
go.drugbank.com/drugs/DB14168ApprovedSarocladium strictum allergenic extract is used in allergenic testing.
Mixtures: New Stock Fungi Mix, New Stock Fungi MixCategories: Non-Standardized Food Allergenic Extract, Non-Standardized Fungal Allergenic ExtractMetastatic Non-Small Cell Lung Cancer
go.drugbank.com/conditions/DBCOND0043377Synonyms: Metastatic Non-small Cell Lung Cancers, Non-small cell lung cancer stage IVNon-infectious Posterior Uveitis Chronic Uveitis
go.drugbank.com/conditions/DBCOND0115089Drugs: Fluocinolone acetonideSynonyms: Non-infectious Posterior Uveitis Chronic UveitisRecurrent Non-small Cell Lung Cancer
go.drugbank.com/conditions/DBCOND0028805Synonyms: Recurrent Non-Small Lung Cell Cancer, Non Small Cell Lung Cancer RecurrentResectable Non-small Cell Lung Cancer
go.drugbank.com/conditions/DBCOND0068626Synonyms: Non-small cell lung cancer NOS, Non-small cell lung cancerDrinabant
go.drugbank.com/drugs/DB05750InvestigationalAVE-1625 is an oral selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant.
Poractant alfa
go.drugbank.com/drugs/DB09113ApprovedInvestigationalIt contains no preservatives. … Poractant alfa is an extract of natural porcine lung surfactant consisting of 99% polar lipids (mainly phospholipids) and 1% hydrophobic low molecular weight proteins (surfactant associated proteins SP-B
Reproxalap
go.drugbank.com/drugs/DB16688InvestigationalReproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis … [L32990] NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.[L32990]
Synonyms: NS-2Regdanvimab
go.drugbank.com/drugs/DB16405ApprovedWithdrawn[A235830,A241995] It received its first full approval in South Korea in September 2021,[A241995] followed by the EU in November 2021.[L39130]